Page last updated: 2024-09-03

umifenovir and cobicistat

umifenovir has been researched along with cobicistat in 5 studies

Compound Research Comparison

Studies
(umifenovir)
Trials
(umifenovir)
Recent Studies (post-2010)
(umifenovir)
Studies
(cobicistat)
Trials
(cobicistat)
Recent Studies (post-2010) (cobicistat)
2342317230075282

Protein Interaction Comparison

ProteinTaxonomyumifenovir (IC50)cobicistat (IC50)
Cytochrome P450 3A4Homo sapiens (human)0.15
Cytochrome P450 2D6Homo sapiens (human)9.2

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Duan, Y; Zhou, C; Zhu, HL1
Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X1
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J1
Chao, CM; Hsueh, PR; Lai, CC1

Reviews

1 review(s) available for umifenovir and cobicistat

ArticleYear
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Carbamates; Cobicistat; COVID-19 Drug Treatment; Darunavir; Dibenzothiepins; Drug Combinations; Drug Therapy, Combination; Humans; Imidazoles; Indoles; Iran; Lopinavir; Morpholines; Pyrazines; Pyridones; Pyrrolidines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Triazines; Valine

2021

Other Studies

4 other study(ies) available for umifenovir and cobicistat

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Advance of promising targets and agents against COVID-19 in China.
    Drug discovery today, 2020, Volume: 25, Issue:5

    Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins

2020
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
    Journal of neurovirology, 2020, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12

2020
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
    Journal of affective disorders, 2020, 12-01, Volume: 277

    Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2

2020